MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5339/qmj.2026.51

Медицинская библиотека · Qatar medical journal · 2026

Function-preserving intracapsular versus superficial parotidectomy for benign parotid tumors: A randomized controlled trial.

Abdulmohaymen Ayman, Abdelbary Sayed R, Abouelgreed Tamer A, Sheikh Abd El-Fattah Al, Elhady Hany Abdelfatah, Futooh Zahraa, Nagaty Mahmoud E, Abdelkader Hamada Rashad, Elhossainy Ahmed F, Shalamesh Mohamed I, Moghazy Alsayed B, Nafea Mohamed A, Farag Hamdy, Osman Esam M, Abbas Mohammed, Ibrahim Islam M, Elkaseer Mohamed Hassan, Mahdy Mohamed, El-Hussieny Mahmoud A, Metwally Ahmed G E, Elrefaey Mohammed M, Lamey Ahmed

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Superficial parotidectomy is the traditional treatment for benign parotid tumors but may be associated with facial nerve dysfunction and other morbidities. Intracapsular parotidectomy has emerged as a function-preserving alternative; however, concerns regarding oncologic safety remain. Randomized evidence comparing both techniques is limited. Therefore, this study aimed to compare their functional and oncologic outcomes.

OBJECTIVE

This study aimed to compare intracapsular parotidectomy and superficial parotidectomy in terms of operative efficiency, complications, facial nerve preservation, and tumor recurrence for benign parotid tumors.

METHODOLOGY: This multicenter randomized controlled trial included patients with benign parotid tumors who were randomly assigned to undergo either intracapsular or superficial parotidectomy between May 2019 and May 2023, in Cairo, Egypt. Functional outcomes, postoperative complications, and recurrence rates were evaluated.

RESULTS

The mean age was 46.3 ± 9.5 years, with a range of 25-65 years. Most patients (84, 70%) were male, while 36 (30%) were female. The intracapsular parotidectomy (ICP) group demonstrated significantly reduced operative time (68.5 ± 12.3 vs. 88.3 ± 14.5 minutes; p = 0.01) and blood loss (120 ± 55.3 vs. 170 ± 50.5 ml; p = 0.001) compared to the superficial parotidectomy (SP) group. Facial nerve injury occurred exclusively in the SP group 9 (15%), including 3 (5%) cases of permanent palsy. Recurrence was observed in 1 (1.7%) ICP case and 3 (5%) SP cases, with no statistically significant difference (P > 0.05). Other complications, including seroma formation and postoperative bleeding, were similarly distributed between the two groups.

CONCLUSION

Intracapsular parotidectomy is a safe, effective, and less invasive alternative to superficial parotidectomy for benign parotid tumors. It offers shorter operative time, reduced bleeding, and improved facial nerve preservation without compromising oncological outcomes. Careful patient selection is essential for optimal results.

Для цитирования: Abdulmohaymen Ayman, Abdelbary Sayed R, Abouelgreed Tamer A, Sheikh Abd El-Fattah Al, Elhady Hany Abdelfatah, Futooh Zahraa, Nagaty Mahmoud E, Abdelkader Hamada Rashad, Elhossainy Ahmed F, Shalamesh Mohamed I, Moghazy Alsayed B, Nafea Mohamed A, Farag Hamdy, Osman Esam M, Abbas Mohammed, Ibrahim Islam M, Elkaseer Mohamed Hassan, Mahdy Mohamed, El-Hussieny Mahmoud A, Metwally Ahmed G E, Elrefaey Mohammed M, Lamey Ahmed. Function-preserving intracapsular versus superficial parotidectomy for benign parotid tumors: A randomized controlled trial.. Qatar medical journal. 2026. DOI: 10.5339/qmj.2026.51.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.